Results 211 to 220 of about 21,948 (303)
Uncertainty persists over whether the benefits of prostate‐specific antigen (PSA) screening outweigh harms from overdiagnosis, a key barrier to population‐wide adoption. Here, English male mortality rates were analyzed alongside long‐term data from the UK Cluster Randomized Trial of PSA Testing for Prostate Cancer (CAP) to estimate age‐specific ...
Adam R. Brentnall +5 more
wiley +1 more source
Antifibrotic therapy for Lower Urinary Tract Symptoms secondary to Benign Prostatic Hyperplasia. [PDF]
Limkar AR, McVary KT, Ricke WA, Lee MS.
europepmc +1 more source
ABSTRACT Introduction Intravesical foreign bodies may remain silent until secondary complications occur. Rectovesical fistula caused by an intravesical foreign body is rare. Case Presentation A 69‐year‐old man presented with urinary frequency and abdominal distension.
Koshiro Hikawa +9 more
wiley +1 more source
Same-Day Discharge After GreenLight Laser Photoselective Vaporization of the Prostate in Patients With Moderate to Severe Lower Urinary Tract Symptoms. [PDF]
Abouelenein M +5 more
europepmc +1 more source
The gut-prostate axis in benign prostatic diseases: Mechanistic pathways and therapeutic implications. [PDF]
Tang Q, Wang K, Fan W, Su Q.
europepmc +1 more source
Fluorescence imaging enables the detection of subclinical actinic cheilitis by revealing early optical alterations in lip tissue. Methylene blue‐mediated photodynamic therapy selectively targets dysplastic areas, enhancing treatment precision and preventing disease progression without adverse effects.
Juliana Cristina Oliverio de Araújo +4 more
wiley +1 more source
Prostatic calculi in men with chronic prostatitis and chronic pelvic pain syndrome: A systematic review (2015-2025). [PDF]
Bhowmik P +5 more
europepmc +1 more source
Cisplatin induces oxidative stress and hepatotoxicity, as evidenced by increased serum biomarkers and oxidative damage parameters. Luteolin, derived from Pistacia terebinthus, mitigates these effects by enhancing antioxidant defense systems and improving cell viability in cancer cell lines.
Özge Temiz +9 more
wiley +1 more source

